The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical Implications From our prostate cancer ...
Credit: Getty Images Study supports the role of PSMA PET for risk stratifying patients with clinically node-positive disease before radical prostatectomy, along with mpMRI and clinical parameters.
False positive PSA results cause unneeded treatments. An expert panel has recommended against routine blood screening for prostate cancer, in a report published Wednesday in The BMJ. The panel, ...
Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...
The percentage of prostate cancer patients with positive lymph nodes increased from 2.4% in 2010 to 4.7% in 2014. The following article is part of conference coverage from the 2018 American Urological ...
A recent BMJ Oncology study screens the prevalence of prostate magnetic resonance imaging (MRI) lesions in men based on age rather than prostate-specific antigen (PSA) levels. Study: Prevalence of MRI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback